I am out of the office until 08/12/2021.

For urgent matters, please contact Miss Jackie LAM, CO(Per)4 at 3107 2571 /
&DH/CO[Per]4.

Note: This is an automated response to your message "Freedom of Information
request - Use of Midazolam in Hong Kong" sent on 25.11.2021 03:50:07 PM.

This is the only notification you will receive while this person is away.

Dear Allyson van de Pol,
Code on Access to Information
Re：Application No. DO EC 2348/21
Our department has received your application for access to information as
per email below. Regarding your questions, our replies are as follows:

For Question 1, Hong Kong Department of Health holds stock of Midazolam
currently.

For Question 2, Department of Health does not have information on the
quantity of Midazolam used in hospitals/ care homes (and any other
institutions) month by month, over the last five years.  Pursuant to
paragraph 1.14 of the Code on Access to Information (the Code), it does
not oblige departments to acquire information not in their possession.  We
are unable to provide the relevant information as requested.  Subject to
your agreement, we shall direct your request to the Hospital Authority
which may have the requested information.  

You may contact the undersigned at 2961 8856 if you need further
assistance.  

Thank you for your attention.
(Mr Shawn HUI)
for Director of Health

----- Forwarded by Shawn PS HUI/DH/HKSARG on 03/12/2021 17:50 -----
From:        Allyson van de Pol <[FOI #893 email]>
To:        FOI requests at Department of Health <[Department of Health request email]>
Date:        25/11/2021 15:53
Subject:        Freedom of Information request - Use of Midazolam in Hong
Kong

--------------------------------------------------------------------------

Dear Department of Health,

May I please ask the following:

-Does Hong Kong hold a stock of Midazolam currently or has it ever held a
stock in the last five years?
-If yes to the above, please advise on the quantity of Midazolam used in
hospitals/ care homes (and any other institutions) month by month, over
the last five years.

Thank you!

Yours faithfully,

Allyson van de Pol

-------------------------------------------------------------------

This is a request under the Code of Access to Information facilitated via
the accessinfo.hk website.

Please use this email address for all replies to this request:
[FOI #893 email]

Is [Department of Health request email] the wrong address for Freedom of Information requests
to Department of Health? If so, please contact us using this form:
[1]https://accessinfo.hk/en/change_request/...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[2]https://accessinfo.hk/en/help/officers

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

References

Visible links
1. https://accessinfo.hk/en/change_request/...
2. https://accessinfo.hk/en/help/officers

收起引用部分

Dear Allyson van de Pol,

Code on Access to Information
Re：Application No. DO EC 2348/21

Our department has received your application for access to information as
per email below.  Your application is now under processing.  According to
paragraph 1.16 of the Code on Access to Information, our department will
inform you of the latest progress of the case separately on or before
24.12.2021.  In the meantime, please contact me at 2961 8856 if you have
any enquiry.

(Mr. Shawn HUI)
for Director of Health

----- Forwarded by Shawn PS HUI/DH/HKSARG on 13/12/2021 17:18 -----

From:        Allyson van de Pol <[FOI #893 email]>
To:        FOI requests at Department of Health <[Department of Health request email]>
Date:        04/12/2021 11:54
Subject:        Internal review of Freedom of Information request - Use of
Midazolam in Hong Kong

--------------------------------------------------------------------------

Dear Department of Health,

Thank you very much.

If you could advise as much detailed information as you can about
Midazolam usage, that would be very kind.

Many thanks

Yours faithfully,

Allyson van de Pol

-----Original Message-----

Dear Allyson van de Pol,

Code on Access to Information

Re：Application No. DO EC 2348/21

Our department has received your application for access to information as

per email below. Regarding your questions, our replies are as follows:

For Question 1, Hong Kong Department of Health holds stock of Midazolam

currently.

For Question 2, Department of Health does not have information on the

quantity of Midazolam used in hospitals/ care homes (and any other

institutions) month by month, over the last five years.  Pursuant to

paragraph 1.14 of the Code on Access to Information (the Code), it does

not oblige departments to acquire information not in their possession.  We

are unable to provide the relevant information as requested.  Subject to

your agreement, we shall direct your request to the Hospital Authority

which may have the requested information.  

You may contact the undersigned at 2961 8856 if you need further

assistance.  

Thank you for your attention.

(Mr Shawn HUI)

for Director of Health

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[FOI #893 email]

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[1]https://accessinfo.hk/en/help/officers

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

References

Visible links
1. https://accessinfo.hk/en/help/officers

收起引用部分

Dear Allyson van de Pol,
Code on Access to Information
Re：Application No. DO EC 2348/21

Our department has received your request for internal review under the
Code on Access to Information (the Code) dated 4 December 2021.  We have,
in accordance with the established procedures and guidelines, conducted an
internal review.  I am authorised to give a reply below.

As mentioned in the first reply dated 3 December 2021, Department of
Health (DH) does not have information on the quantity of Midazolam used in
hospitals/ care homes (and any other institutions) month by month, over
the last five years since they are not managed by DH. We only have
Midazolam Injection 5mg/ml stocked at clinic dispensaries operated under
our department. As at 30.11.2021, there were 141 ampoules of Midazolam
Injection 5mg/ml at our clinic dispensaries.  The monthly stock level
remains the same in 2021.  

If you think that the DH has failed to properly apply any provision of the
Code, you may complain to The Ombudsman.  The address of the Office of The
Ombudsman is –

30/F, China Merchants Tower
Shun Tak Centre
168-200 Connaught Road Central
Hong Kong

Telephone: 2629 0555
Fax: 2882 8149
Email: [email address]

Thank you for your attention.

(Ms Teresa HO)
for Director of Health
From:        Shawn PS HUI/DH/HKSARG
To:        Allyson van de Pol <[FOI #893 email]>
Date:        13/12/2021 17:22
Subject:        *Restricted: Fw: Internal review of Freedom of Information
request - Use of Midazolam in Hong Kong

--------------------------------------------------------------------------

Dear Allyson van de Pol,

Code on Access to Information
Re：Application No. DO EC 2348/21

Our department has received your application for access to information as
per email below.  Your application is now under processing.  According to
paragraph 1.16 of the Code on Access to Information, our department will
inform you of the latest progress of the case separately on or before
24.12.2021.  In the meantime, please contact me at 2961 8856 if you have
any enquiry.

(Mr. Shawn HUI)
for Director of Health

From:        Allyson van de Pol <[FOI #893 email]>
To:        FOI requests at Department of Health <[Department of Health request email]>
Date:        04/12/2021 11:54
Subject:        Internal review of Freedom of Information request - Use of
Midazolam in Hong Kong

--------------------------------------------------------------------------

Dear Department of Health,

Thank you very much.

If you could advise as much detailed information as you can about
Midazolam usage, that would be very kind.

Many thanks

Yours faithfully,

Allyson van de Pol

-----Original Message-----

Dear Allyson van de Pol,

Code on Access to Information

Re：Application No. DO EC 2348/21

Our department has received your application for access to information as

per email below. Regarding your questions, our replies are as follows:

For Question 1, Hong Kong Department of Health holds stock of Midazolam

currently.

For Question 2, Department of Health does not have information on the

quantity of Midazolam used in hospitals/ care homes (and any other

institutions) month by month, over the last five years.  Pursuant to

paragraph 1.14 of the Code on Access to Information (the Code), it does

not oblige departments to acquire information not in their possession.  We

are unable to provide the relevant information as requested.  Subject to

your agreement, we shall direct your request to the Hospital Authority

which may have the requested information.  

You may contact the undersigned at 2961 8856 if you need further

assistance.  

Thank you for your attention.

(Mr Shawn HUI)

for Director of Health

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[FOI #893 email]

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[1]https://accessinfo.hk/en/help/officers

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

References

Visible links
1. https://accessinfo.hk/en/help/officers

收起引用部分